InvestorsHub Logo
Followers 26
Posts 2881
Boards Moderated 0
Alias Born 12/05/2021

Re: hoffmann6383 post# 451509

Tuesday, 03/15/2022 2:38:03 PM

Tuesday, March 15, 2022 2:38:03 PM

Post# of 701599

Release it on their own terms in a journal that describes this to the physicians and decisions makers that will ultimately determine whether this is accepted as the SoC.



If that were truly the case then they could have waited fo PR this
https://nwbio.com/northwest-biotherapeutics-announces-commencement-of-cancer-vaccine-production-at-its-sawston-uk-facility/

and start ramping up and offering the commercial sales of DCVAX L until after topline is released.

Now they are COMMERCIALLY (SO not because of reasons to provide trial patients or to have patients that could not be served during the trial or whatever compassionate use) no again COMMERCIALLY thus for PROFIT SELLING DCCAX L to patients while sitting on unblinded data without telling patients and their MDs if the expensive trial is efficient and in what manner just leaving them to guess.

Yeah I have a Big F problem with that since Feb 17
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News